X Chromosome Escape Gene KDM6A Directly Links Sex‑Specific Gut Butyrate Utilization to Colonocyte Energetics and Sex Differences in Inflammaging
Hypothesis
The X‑linked epigenetic regulator KDM6A, expressed at higher dosage in XX cells, cell‑autonomously augments colonic expression of the butyrate transporter SLC5A8 and the mucin gene MUC2. This drives increased luminal butyrate uptake, enhances colonocyte ATP production, and shapes a microbiome enriched in butyrate‑producers, thereby providing a mechanistic basis for the female advantage in gut‑mediated longevity.
Mechanistic Model
KDM6A demethylates H3K27me3 at promoters of metabolic and barrier genes. In intestinal epithelial cells, higher KDM6A activity in XX individuals sustains an open chromatin state at Slc5a8 and Muc2, elevating their transcription. Greater SLC5A8 boosts butyrate import, which fuels mitochondrial oxidation and supplies ~70‑80% of colonocyte energy needs【https://pmc.ncbi.nlm.nih.gov/articles/PMC8002420/】. Elevated MUC2 thickens the mucus layer, favoring colonization by mucin‑utilizing, butyrate‑producing taxa such as Bifidobacterium spp., a pattern observed in the world’s oldest woman【https://microbiomepost.com/gut-microbiota-linked-to-healthy-longevity-in-the-worlds-oldest-woman/】. The resulting rise in circulating butyrate reduces systemic inflammation via GPR109A signaling on macrophages, reinforcing the stronger innate immunity seen in female centenarians【https://www.fightaging.org/archives/2025/03/differences-in-the-gut-microbiome-and-immune-function-in-male-versus-female-centenarians/】. Conversely, XY cells with a single KDM6A copy exhibit lower Slc5a8/Muc2 expression, diminished butyrate uptake, a less beneficial microbiome, and accelerated inflammaging.
Predictions & Experimental Approach
- Baseline comparison – In young adult mice, colonic Slc5a8 and Muc2 mRNA and protein levels will be significantly higher in XX versus XY littermates, correlating with higher luminal butyrate concentrations and a greater relative abundance of Bifidobacterium.
- Loss‑of‑function test – Conditional knockout of Kdm6a in intestinal epithelium (Vil‑Cre;Kdm6a^fl/fl) of XX females will reduce Slc5a8/Muc2 expression by ~40‑50%, lower colonocyte ATP (measured via luciferase assay), decrease fecal butyrate by ~30%, and shift microbiota toward reduced Bifidobacterium and increased proteobacteria.
- Rescue experiment – Supplementing Kdm6a‑deficient XX mice with sodium butyrate (150 mM in drinking water) will restore colonocyte ATP to wild‑type levels, normalize mucus thickness (histology), and ameliorate age‑related increases in serum IL‑6 and TNF‑α.
- Human relevance – Analyzing publicly available colonic biopsy transcriptomes (GTEx) stratified by sex and age will reveal that higher KDM6A expression predicts elevated SLC5A8 and MUC2 levels, and that this gene‑expression signature correlates with higher fecal butyrate (from metaproteomic datasets) and lower circulating CRP.
These predictions are falsifiable: if Kdm6a loss does not alter butyrate transporter expression or microbiome composition, or if butyrate supplementation fails to rescue colonocyte energetics and inflammation, the hypothesis would be refuted. Confirming the link would reposition the X chromosome as a regulator of host‑microbe metabolic crosstalk that directly shapes sex differences in gut‑driven aging.